Info Cubic achieves new ISO 9001:2015 Certification.

Info Cubic, LLC, a leading employment screening company, is proud to announce that we have achieved ISO 9001:2015 Certification.

DENVER, COLORADO, USA, September 19, 2017 /EINPresswire.com/ — Info Cubic, LLC, a leading employment screening company, is proud to announce that we have achieved ISO 9001:2015 Certification.

The International Organization for Standardization (ISO) was formed in 1947. Today, ISO is an independent, non-governmental international organization with members from 162 countries and 786 technical bodies. They have created more than 21,000 International Standards containing practical information and best practices and often describe an agreed way of doing something or a solution to a global problem.

“We’ve been ISO 9001:2008 Certified since October of 2010 but wanted to continue to push our organization to be the best that it can be” said Eden Hutchinson, Info Cubic’s Manager of Quality Assurance. “The new ISO 9001:2015 Standard is more up-to-date and reflective of service orientated organizations allowing us to achieve conformity of products and services in our efforts to exceed our clients’ needs and expectations.”

Info Cubic’s long time focus on quality and client service is at the very core of our business. The Plan-Do-Check-Act cycle (PDCA) is a natural fit in our operations and service departments.

While anyone can claim to be the best in the industry, Info Cubic’s ISO 9001:2015 Certification, NAPBS Accreditation and back to back Bakers Dozen awards for Customer Service are all concrete proof that we are committed to doing what we say we’re going to do and that we have substantiating evidence to back it up.

Imagine…working with people who love what they do!

About Info Cubic
Headquartered in Denver, Colorado, Info Cubic LLC is a leading provider of employment screening and drug testing for organizations of any size and structure. Info Cubic prides itself on providing first-class customer service, industry-leading turnaround times, maximum accuracy and legal compliance expertise. Info Cubic is accredited through the National Association of Professional Background Screeners (NAPBS), ISO 9001:2015 certified, Workforce Magazine Hot Listed and multi-year award winners of HRO Today Baker’s Dozen Customer Satisfaction Ratings. Visit www.infocubic.com or call (877) 360-INFO (4636) for additional information.

Jason Rennie
INFO CUBIC LLC
609-434-2755
email us here


Source: EIN Presswire

New White Paper Details Bureaucracy, Deadly Delays, and Apathy by Pharmacy Benefit Managers

COA White Paper Continues to Share True Patient-PBM Stories and How They Hurt Cancer Patients


Profit-driven PBM middlemen have become a scourge on our health care system, hurting sick cancer patients that desperately need these drugs as they battle this devastating disease.”

— Ted Okon, Executive Director of COA

WASHINGTON, DISTRICT OF COLUMBIA, UNITED STATES, September 19, 2017 /EINPresswire.com/ — Today, the Community Oncology Alliance (COA) and the Community Oncology Pharmacy Association (COPA) released a new white paper sharing more real patient stories detailing the negative impact pharmacy benefit managers (PBMs) have on cancer care.

Compiling stories from cancer patients and physicians, the white paper “Bureaucracy, Deadly Delays, and Apathy: Pharmacy Benefit Manager Horror Stories”, presents stories collected from community oncology practices over the last year. The serious, sometimes dangerous, stories told in the paper include PBM bureaucracies failing cancer patients through complete indifference to sick patients, dangerous mistakes, and deadly bureaucracies.

• Read the full white paper “Bureaucracy, Deadly Delays, and Apathy: Pharmacy Benefit Manager Horror Stories — Part III”.

“Profit-driven PBM middlemen have become a scourge on our health care system, hurting sick cancer patients that desperately need these drugs as they battle this devastating disease,” said Ted Okon, Executive Director of COA. “How many more horror stories must we hear before action is taken to finally stop PBM abuses? Congress needs to act now. Patients should not have to suffer because of these large, secretive bureaucracies.”

This is the third in a white paper series exposing the abuses of PBMs produced by COA. The first, “Delay, Waste, and Cancer Treatment Obstacles: The Real-Life Patient Impact of Pharmacy Benefit Managers (PBM)” was released in April at the 2017 Community Oncology Conference; the second “Unaccountable Benefit Managers: Real Horror Stories of How PBMs Hurt Patient Care” was released in June 2017.

The paper is being released during a meeting of the COA Board of Directors outside of Washington, DC. One of the areas of focus will be PBMs and the adverse impact that they are having on the care of cancer patients. It complement the website www.PBMAbuses.com launched by COA as a place to support patient education and advocacy on PBM issues. Visitors to the site will be able to access the patient horror stories series, educational videos, and more.

Read the full white paper “Bureaucracy, Deadly Delays, and Apathy: Pharmacy Benefit Manager Horror Stories — Part III” at http://bit.ly/pbmstoriesv3.

Nicolas Ferreyros
Community Oncology Alliance
6466854262
email us here


Source: EIN Presswire

Global Active Pharmaceutical Ingredients (API) Market 2017 Share, Trend, Segmentation And Forecast To 2022

Active Pharmaceutical Ingredients (API) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022

PUNE , MAHARASHTRA, INDIA, September 19, 2017 /EINPresswire.com/ — Active Pharmaceutical Ingredients (API) Industry

Description

Wiseguyreports.Com Adds “Active Pharmaceutical Ingredients (API) -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2022” To Its Research Database

The Global Active Pharmaceutical Ingredients (API) market accounted for $121.4 billion in 2014 and is expected to grow at a CAGR of 6.4% to reach $198.8 billion by 2022. Patent expiration of prominent drugs, government initiatives, regional penetration, increasing aged population are some of the factors that are driving the market growth. Strict validation and safety guidelines stated by WHO and fragmented market are the factors that are hampering the API market growth.The Global Active Pharmaceutical Ingredients (API) market is segmented on the basis of type of API, manufacturers, therapeutic area and geography. On the basis of type of API, the active pharmaceutical ingredients market is segmented into synthetic chemical API and biological API. By type of manufacturers, the market is categorized into captive (or in-house) and contract manufacturing.

By therapeutic applications, the market is segmented into oncology, anti-Infectives, cardiovascular and hematopoietic system, gastrointestinal disorder, hormonal-related disorder, metabolic disorder, musculo-skeletal disorder and others. Anti-infectives application commanded the largest market share in 2014, whereas oncology is expected to be the fastest growing application with a CAGR of more than 8.8 during the forecast period.

By geography, it is segmented into North America, Europe, Asia Pacific and Rest of the World. North America is the global leader in the active pharmaceuticals ingredients market due to its highly developed research and development projects in the field of therapies, medical sciences, and drugs. Asia Pacific is projected to be the fastest growing regional market with a CAGR of more than 8%. The fast growth is attributed to patent expirations of drugs, and favourable investments in medical research.

Request for Sample Report @ https://www.wiseguyreports.com/sample-request/active-pharmaceutical-ingredients-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022

Some of the prominent players in the active pharmaceutical ingredients (API) market include WuXi Apptec, Teva Pharmaceutical, Pfizer, Novartis, Mylan, BASF, Actavis, Cambrex, Dr. Reddy’s Laboratories and Novartis.

What our report offers: 
– Market share assessments for the regional and country level segments 
– Market share analysis of the top industry players 
– Strategic recommendations for the new entrants 
– Market forecasts for a minimum of 8 years of all the mentioned segments, sub segments and the regional markets 
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) 
– Strategic recommendations in key business segments based on the market estimations 
– Competitive landscaping mapping the key common trends 
– Company profiling with detailed strategies, financials, and recent developments 
– Supply chain trends mapping the latest technological advancements

Complete report details @ https://www.wiseguyreports.com/reports/active-pharmaceutical-ingredients-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022 

Executive Summary 

2 Preface 
2.1 Abstract 
2.2 Research Scope 
2.3 Research Methodology 
2.4 Research Sources 

3 Market Trend Analysis 
3.1 Introduction 
3.2 Drivers 
3.3 Restraints 
3.4 Opportunities 
3.5 Threats 

4 Porters Five Force Analysis 
4.1 Bargaining power of suppliers 
4.2 Bargaining power of buyers 
4.3 Threat of substitutes 
4.4 Threat of new entrants 
4.5 Competitive rivalry 

9 Key Developments 
9.1 Agreements, Partnerships, Collaborations and Joint Ventures 
9.2 Acquisitions & Mergers 
9.3 New Product Launch 
9.4 Expansions 
9.5 Other Key Strategies 

10 Company Profiling 
10.1 Zoetis (U.S.) 
10.2 Merck Animal Health (U.S.) 
10.3 Merial Inc. (Sanofi) (France) 
10.4 Elanco Animal Health (U.S.) 
10.5 Boehringer Ingelheim (Germany) 
10.6 Bayer Healthcare (Germany) 
10.7 Bioniche Animal Health (Canada) 
10.8 Heska Co. (U.S.) 
10.9 Ceva Animal Health, Inc. 
10.10 Virbac

Make an enquiry before buying this report @ https://www.wiseguyreports.com/enquiry/active-pharmaceutical-ingredients-global-market-outlook-trends-forecast-and-opportunity-assessment-2014-2022 

Continued…

Contact Us: Sales@Wiseguyreports.Com Ph: +1-646-845-9349 (Us)  Ph: +44 208 133 9349 (Uk)

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

US Neurofeedback System 2017 – Global Market Size, Trends, Opportunities and Growth Forecast to 2022

Wiseguyreports.Com Publish New Market Research Report On-“US Neurofeedback System 2017 – Global Market Size, Trends, Opportunities and Growth Forecast to 2022”.

PUNE, INDIA, September 19, 2017 /EINPresswire.com/ —

US Neurofeedback System Market 2017

Executive Summary
Neurofeedback is a non-invasive method of direct brain function training. It is also a type of biofeedback and is therefore, also called EEG Biofeedback. It uses the electrodes (which act like tiny microphones) placed on the client's scalp to record and amplify the EEG, or brainwaves and control auditory, visual, and/or tactile feedback which allows learning to take place. This operant learning initiates self-regulation and enhances relaxation, both necessary components of good brain function.

Scope of the Report:
This report focuses on the Neurofeedback System in United States market, to split the market based on manufacturers, states, type and application.

Market Segment by Manufacturers, this report covers
BrainMaster Technologies
BEE Medic
Brainquiry
Mitsar
Thought Technology
Mind Media
Wearable Sensing

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/2295431-united-states-neurofeedback-system-market-by-manufacturers-states-type-and-application

Market Segment by States, covering
California
Texas
New York
Florida
Illinois

Market Segment by Type, covers
Slow Cortical Potential Neurofeedback (SCP-NF)
Low-energy Neurofeedback System (LENS)
Hemoencephalographic (HEG) neurofeedback
Other

Market Segment by Applications, can be divided into
ADHD Treatment
Other Clinic Use
Non-medical

There are 17 Chapters to deeply display the United States Neurofeedback System market.
Chapter 1, to describe Neurofeedback System Introduction, product type and application, market overview, market analysis by States, market opportunities, market risk, market driving force;
Chapter 2, to analyze the manufacturers of Neurofeedback System, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the United States market by States, covering California, New York, Texas, Illinois and Florida, with sales, price, revenue and market share of Neurofeedback System, for each state, from 2012 to 2017;
Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type, application, from 2012 to 2017;
..…..Continued

Complete Report Details @ https://www.wiseguyreports.com/reports/2295431-united-states-neurofeedback-system-market-by-manufacturers-states-type-and-application

Table of Contents –Analysis of Key Points

1 Market Overview
1.1 Neurofeedback System Introduction
1.2 Market Analysis by Type
1.3 Market Analysis by Applications
1.4 Market Analysis by States
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force

2 Manufacturers Profiles
2.1 BrainMaster Technologies
2.1.1 Profile
2.1.2 Neurofeedback System Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 BrainMaster Technologies Neurofeedback System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.1.4 Business Overview
2.1.5 BrainMaster Technologies News
2.2 BEE Medic
2.2.1 Profile
2.2.2 Neurofeedback System Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 BEE Medic Neurofeedback System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2.4 Business Overview
2.2.5 BEE Medic News
2.3 Brainquiry
2.3.1 Profile
2.3.2 Neurofeedback System Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Brainquiry Neurofeedback System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3.4 Business Overview
2.3.5 Brainquiry News
2.4 Mitsar
2.4.1 Profile
2.4.2 Neurofeedback System Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Mitsar Neurofeedback System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4.4 Business Overview
2.4.5 Mitsar News
2.5 Thought Technology
2.5.1 Profile
2.5.2 Neurofeedback System Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Thought Technology Neurofeedback System Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5.4 Business Overview
2.5.5 Thought Technology News
2.6 Mind Media
2.6.1 Profile
2.6.2 Neurofeedback System Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
..…..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2295431

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

GroomX providing softskills training for the Health Care Sector in India

GroomX providing softskills training for the Health Care Sector in India

BANGALORE, KARNATAKA, INDIA, September 19, 2017 /EINPresswire.com/ — Welcome to GroomX Finishing Academy. A training and development organization which provides complete end-to-end training solutions with a mission. We work with the client to provide high quality training that will seamlessly transition the employees to a higher level of competence.

Importance:

Patients and their visitors depend on hospital employees to go the extra mile to provide customer service that takes into account the intimidation they feel simply visiting a hospital.
Our Training for Hospital Employees program delivers proven methods that will provide insight into how human behavior affects individual customer needs and will enable any hospital employee to provide lasting customer satisfaction to patients.

​Objective​:

Our Training for Hospital Employees program teaches employees and the administrative staff the ability to recognize patient and visitor behavioural styles and to respond according to individual needs.
Participants who attend this session will learn the methods required to ensure that every person who visits a hospital, be it a patient or a visitor, leaves as a satisfied customer.

Soft Skill Training is Often Overlooked
When it comes to skills in employment, the first line of emphasis is typically towards abilities, training and knowledge of specific skill sets. These are referred to as hard skills. Soft skills, however, are often overlooked, yet they also play an important role in day-to-day operations.
Soft skills are personal attributes that enhance an individual’s interactions, job performance and career prospects. Unlike hard skills, which are about a person’s skill set and ability to perform a certain type of task or activity, soft skills are interpersonal and broadly applicable.
Training Process
Pre-training questionnaire is sent prior to training session.
Execution of the training.
Post-training evaluation.

Methodology :

Combination of : Role plays’ | Activities | Games | Case Studies & PPT’s | Audio & Video clips | Mockup segment’s etc.

During the sessions, training may happen but learning may not. To avoid this contradiction, we take up role of a learning facilitator by making interactive training sessions, customizing training programs that meet client’s requirements.

Few Clients : GroomX KWPL

Manipal Hospitals India | Sagar Hospital | Green Apple | Radiant Health Care |
Maharaja Agrasen Hospital | Manipal Ankur and many many more.

Epilogue
At GroomX, we’re talking about technology everyday—and not just with a variety of clients, but with leading vendors—about industry trends and real-life challenges.
And because of our close partnership with leading vendors, GroomX is positioned to help businesses like yours leverage our knowledge experts to discuss strategies, implementation and troubleshooting.
Continuous Up gradation : GroomX offers continuous up gradation of the trainings once designed. We also work closely with leadership team of your organisation to introduce the new trainings and modify/alter existing trainings.

Jal Dani
GroomX Knowledge Works Pvt Ltd
+91-9036111000
email us here


Source: EIN Presswire

The use of Animal Models in Pre-Clinical Drug Development

Superbugs USA 2017

Superbugs USA 2017

UNT Health Science Centre to lead interactive workshop at the next annual USA meeting on Superbugs and Superdrugs

Very enjoyable and informative meeting”

— Micromyx, Past Attendee Testimonial

ISELIN, NEW JERSEY, UNITED STATES, September 19, 2017 /EINPresswire.com/ — SMi Group’s USA conference on Superbugs & Superdrugs is set to return to Iselin New Jersey this fall on November 13th and 14th. Not only will the next instalment in the global series feature an agenda that hones in on expert led approaches to strengthen the antibiotic pipeline, but it will also offer hands on training through a post-conference interactive workshop taking place on November 15th.

Hosted by the UNT Health Science Centre and led by William Weiss, Director, Pre-Clinical Services; and Mark Pulse, Assistant Director; the workshop on "The Use of Animal Models in Pre-Clinical Drug Development" will focus on the transition from in vitro activity to in vivo efficacy; the choice of the right animal model for proof of concept studies; and provide examples of relevant animal models with supportive data and interpretation of results as it relates to the clinical condition.

William Weiss has extensive experience in pre-clinical microbiology research and development efforts focused on the discovery & development of new antimicrobial agents. He has worked on numerous antibacterial programs including the development of the marketed antibiotics; Suprax, Zosyn and Tygacil.

Mark Pulse has been directly involved in the development of multiple in vivo models that have included GI- and respiratory-associated infectious diseases, device-associated (biofilm) infections and pharmacokinetic studies.

Other notable speakers on the agenda will include representatives from: Janssen, BARDA, CARB-X, Pfizer, MedImmune, Visterra, Contrafect, Centauri Therapeutics, Microbiotix and Merck.

Further information on Superbugs & Superdrugs USA is available at http://www.superbugs-usa.com/ein

Superbugs & Superdrugs USA will take place on 13th & 14th November at the Renaissance Woodbrigde Hotel in Iselin, New Jersey. Sponsored by Merck and Soligenix.

— END —

Contact Information:
For all media inquiries contact Teri Arri on Tel: +44 (0)20 7827 6162 / Email: tarri@smi-online.co.uk

About SMi Group:
Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world's most forward thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk

About UNT Health Science Centre
The Pre-Clinical Services group in the UNT System College of Pharmacy at the University of North Texas Health Science Center conducts industry sponsored research studies utilizing established models of both acute and chronic bacterial infections in several different animal species including pharmacokinetic/pharmacodynamic studies with bioanalytical LCMS/HPLC analysis. Infection models or protocols other than those described herein can also be develop and validated as required to meet the more specific needs of interested Sponsors. UNTHSC Pre-clinical Services together has over 35 years of direct pharmaceutical and specialized biotech experience in the performance of therapeutic efficacy models and drug discovery/development. The group utilizes this experience to guide the drug discovery process, from protocol design to implementation and analysis for compound lead selection. Studies are conducted in state-of-the-art laboratory and vivarium facilities with excellent support staff and services.

Teri Arri
SMi Group
2078276162
email us here


Source: EIN Presswire

Connected Medical Device Market Analysis 2017 (By Segment, Key Players and Applications) and Forecasts To 2024

Connected Medical Device Market Share, Opportunities, Segmentation and Forecast to 2024

PUNE, INDIA, September 19, 2017 /EINPresswire.com/ — Pune, India, 19th September 2017: WiseGuyReports announced addition of new report, titled “Global Connected Medical Device Market Outlook 2024, Global Opportunity and Demand Analysis, Market Forecast, 2016-2024”.

Market Overview
Advanced mobile technology has the major contribution in improving medical conditions of patients mainly in Africa and Latin America region. Nearly 70% of world’s population is adopting health applications due to its accuracy and trustworthy health information. Rising demand of health applications and advance medical treatments is fostering the digital health and connected medical device market across the globe. More than 60% of health apps were introduced by major pharmaceutical companies in 2014. Digitalization and inclination of patients towards healthier lifestyle is increasing the adoption of smart medical devices which can perform remote monitoring is bolstering the demand of connected medical devices. The collaboration of major verticals such as pharmaceuticals, data analytics, cloud technology and Internet of Things (IoT) is also transforming the healthcare industry.

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2111663-global-connected-medical-device-market-outlook-2024-global-opportunity-and-demand

Growing awareness and importance of development in advanced healthcare solutions is expected to boost the R&D investments in the connected medical devices market. For instance, in 2017 Healthcare Research and Quality (AHRQ), offers funds to stimulate the health information technology systems and improve primary care in the U.S., which is likely to fuel the growth of connected medical device market in this region. In 2015, USD 35 million was invested by the government of Scotland to improve remote monitoring facilities and home health diagnosis & treatment. Countries such as Chile and Argentina are also increasing their health expenditure to offer better healthcare facilities in the region.

Market Segmentation
The segmentation of global connected medical devices market can be done on the following basis:
• Based on Product Type
o Blood Pressure Monitors
o ECG Monitors
o Safety Monitoring Devices
o Activity Monitoring Devices
o Others ( Pulse oximeters, Pill Dispensers)
• By Devices
o Wearables
o Non-Wearables
• Based on Application
o Remote Monitoring
o Consultation and Diagnosis services
o Treatment services
o Fitness and Wellness services
• By End-User
o Hospitals
o Clinics
o Individual Consumers
o Home Healthcare
Based on Geography

o North America (U.S. & Canada) {Market Size (USD Billion), Growth Analysis (%) and Product Sales (Units)}
o Latin America (Brazil, Mexico & Rest of Latin America) {Market Size (USD Billion), Growth Analysis (%) and Product Sales (Units)}
o Europe (The U.K., Germany, France, Italy, Spain, Poland, Sweden & RoE) {Market Size (USD Billion), Growth Analysis (%) and Product Sales (Units)}
o Asia-Pacific (China, India, Japan, Singapore, South Korea, Australia, New Zealand, Rest of Asia) {Market Size (USD Billion), Growth Analysis (%) and Product Sales (Units)}
o Middle East & Africa (GCC, South Africa, North Africa, RoMEA) {Market Size (USD Billion), Growth Analysis (%) and Product Sales (Units)}
o Rest of World {Market Size (USD Billion), Growth Analysis (%) and Product Sales (Units)}

Market Size and Forecast (2016-2024)
In January 2017, the FDA issued specific safety communication guidelines for web connected medical devices to reduce the risk for unauthorized access of patient’s data. Favorable government reimbursement policies associated with healthcare sector is likely to fuel the growth of connected medical device market in North America region. North America connected medical device market is the dominating region and acquired approximately 55% of the global connected medical devices market in 2015. North America connected medical device market is expected to reach USD 29.2 billion by 2024 from USD 11.2 billion in 2016, by registering a CAGR of 12.7% over the forecast period. Global connected medical devices market is in its embryonic stage and occupied 6% share of total medical device market in 2016 and is expected to witness a healthy growth in near future. Moreover, the global connected medical device market is anticipated to reach USD 73.1 billion by 2024 from USD 17.0 billion in 2016 and predicted to grow at an exponential CAGR of 20.0% during the forecast period, 2016-2024.
On the other hand, Europe spends nearly 10% of its GDP on healthcare industry and is one of the most diverse regions which primarily focus on innovative medical technology, products and services. Countries such as Germany, France, the United Kingdom, and Sweden are increasing strategic investment in research and development sector for the advancement of medicine and bioscience technology. Europe medical technology market was valued over USD 120 billion with 500,000 registered medical technologies in 2016. Europe connected medical device market is projected to occupy 25% of the global connected medical devices market during the forecast period of 2016-2024.
Latin America and Middle East and Africa regions are experiencing limited growth in connected medical device market. Major part of African countries and Latin America are affected due to poor medical facilities. In 2015, Brazil and Mexico invested over 6% of their GDP in healthcare industry. However, lack of awareness, dearth of healthcare facilities and poor quality of health services in low income countries is one of the major obstacles which is hindering the growth of Latin America connected medical devices market. Although, government is investing to improve healthcare facilities and adopting advance medical technologies which is expected to create business opportunities for connected medical device manufacturers.

Market Drivers and Challenges
Market Drivers
Rise in ageing population with increasing number of multiple chronic health issues is raising the need for extensive care and monitoring across the globe. Thus, elderly population is mainly inclining towards the adoption of connected medical devices for effective care and treatment through remote monitoring. Rising consumer awareness is the main factor which is impelling the global market for connected medical devices. Furthermore, growing popularity of wearable medical devices among consumers which are capable of detecting diabetes at an early stage is up surging the connected medical device market across the globe. High adoption of smart phones, mobile platforms and applications which helps in monitoring health issues reduces the patient admission rate in hospitals. Connected medical devices offers improvement in quality of patient care and cost reduction of health treatments. Moreover, increasing demand of point of care

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

A New Powerful Blood Test to Detect Your Risk of a Heart Attack or Stroke

Cardiac test Calgary

PULS Cardiac Test

PULS Cardiac Test Calgary

Calgary's Heart Fit Clinic is the only one that offers the revolutionary P.U.L.S. Cardiac Test to detect risk of heart attack or stroke in the next five years.

The majority of heart attack and strokes occur with blockages that are less than 50%. Therefore routine cholesterol and exercise stress tests will miss these vulnerable blockages”

— Diamond Fernandes

CALGARY, ALTA, CANADA, September 19, 2017 /EINPresswire.com/ — Calgary’s Heart Fit Clinic now offers The P.U.L.S. (Protein Unstable Lesion Signature) Cardiac Test. This test has received significant attention within the international medical community as an effective diagnostic and predictive tool that allows physicians to identify patients with subclinical, asymptomatic heart disease, who may otherwise be unaware they are at risk of experiencing an acute cardiac event. A major issue for physicians is being able to accurately detect the disease, since most patients present with no signs or symptoms before a fatal or debilitating heart attack.

Cardiovascular disease remains the leading cause of death and hospitalization in Canada, but it is 80% preventable with early detection and treatment. Physicians rely heavily on the Framingham heart score to estimate cardiovascular risk in prevention of cardiovascular diseases. However, the majority of patients who present in the hospital have normal to borderline heart scores along with no prior signs of symptoms.

“The majority of heart attacks and strokes occur with blockages that are less than 50%. Therefore, routine cholesterol and exercise stress tests will miss these vulnerable blockages.” says Diamond Fernandes, director of Heart Fit Clinic. Heart disease is an universal disease and now family physicians and cardiologists can use the PULS Cardiac Test to improve patient care. This can include aggressive lifestyle modification with exercise, nutrition and stress management along with, optimal medical therapy.

The Heart Fit Clinic’s treatment plan includes aggressive lifestyle modification therapy along with External Counterpulsation to prevent fatal heart attacks and strokes.

The PULS Cardiac Test is a non-invasive blood test that measures the body’s immune response to coronary artery injury in patients with no symptoms of heart disease. The body’s response to coronary artery injury frequently causes formation of lesions in the coronary artery wall, which may become unstable and rupture, leading to the formation of a blood clot, the most common cause of heart attacks.

The Heart Fit Clinic can now predict the likelihood patients will experience an Acute Coronary Syndrome (ACS event) within a 5-year period. Identifying these vulnerable patients before they have a cardiac event guides physicians to improve patient care by allowing physicians to implement potentially life-saving prevention plans.

For more information please contact Heart Fit Clinic, info@heartfit.ca 403-870-4348.

Diamond Fernandes
Heart Fit Clinic
403-870-4348
email us here

PULS Cardiac Test


Source: EIN Presswire

Global Baby Fruit Juice Market 2017 – Industry Analysis, Size, Share, Strategies and Forecast to 2022

Wiseguyreports.Com Adds “Baby Fruit Juice Market: Demand, Growth, Opportunities and Analysis of Top Key Player Forecast To 2022” To Its Research Database

PUNE, INDIA, September 19, 2017 /EINPresswire.com/ — Global Baby Fruit Juice Industry

This report studies Baby Fruit Juice in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering
Coca-Cola
Fresh Del Monte Produce
Dr Pepper Snapple
Nestlé
PepsiCo

Try Sample Report @ https://www.wiseguyreports.com/sample-request/898950-global-baby-fruit-juice-market-research-report-2017

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Baby Fruit Juice in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Southeast Asia
India
Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Ambient
Chilled
Split by application, this report focuses on consumption, market share and growth rate of Baby Fruit Juice in each application, can be divided into
Supermarkets and Hypermarkets
On-trade
Independent Retailers
Convenience Stores

Buy now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=898950

Some Major Points from Table of content:

3 Global Baby Fruit Juice Production, Revenue (Value) by Region (2012-2017)
3.1 Global Baby Fruit Juice Production and Market Share by Region (2012-2017)
3.2 Global Baby Fruit Juice Revenue (Value) and Market Share by Region (2012-2017)
3.3 Global Baby Fruit Juice Production, Revenue, Price and Gross Margin (2012-2017)
3.4 North America Baby Fruit Juice Production, Revenue, Price and Gross Margin (2012-2017)
3.5 Europe Baby Fruit Juice Production, Revenue, Price and Gross Margin (2012-2017)
3.6 China Baby Fruit Juice Production, Revenue, Price and Gross Margin (2012-2017)
3.7 Japan Baby Fruit Juice Production, Revenue, Price and Gross Margin (2012-2017)
3.8 Southeast Asia Baby Fruit Juice Production, Revenue, Price and Gross Margin (2012-2017)
3.9 India Baby Fruit Juice Production, Revenue, Price and Gross Margin (2012-2017)

4 Global Baby Fruit Juice Supply (Production), Consumption, Export, Import by Regions (2012-2017)
4.1 Global Baby Fruit Juice Consumption by Regions (2012-2017)
4.2 North America Baby Fruit Juice Production, Consumption, Export, Import (2012-2017)
4.3 Europe Baby Fruit Juice Production, Consumption, Export, Import (2012-2017)
4.4 China Baby Fruit Juice Production, Consumption, Export, Import (2012-2017)
4.5 Japan Baby Fruit Juice Production, Consumption, Export, Import (2012-2017)
4.6 Southeast Asia Baby Fruit Juice Production, Consumption, Export, Import (2012-2017)
4.7 India Baby Fruit Juice Production, Consumption, Export, Import (2012-2017)

5 Global Baby Fruit Juice Production, Revenue (Value), Price Trend by Type
5.1 Global Baby Fruit Juice Production and Market Share by Type (2012-2017)
5.2 Global Baby Fruit Juice Revenue and Market Share by Type (2012-2017)
5.3 Global Baby Fruit Juice Price by Type (2012-2017)
5.4 Global Baby Fruit Juice Production Growth by Type (2012-2017)

6 Global Baby Fruit Juice Market Analysis by Application
6.1 Global Baby Fruit Juice Consumption and Market Share by Application (2012-2017)
6.2 Global Baby Fruit Juice Consumption Growth Rate by Application (2012-2017)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries

7 Global Baby Fruit Juice Manufacturers Profiles/Analysis
7.1 Coca-Cola
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Baby Fruit Juice Product Type, Application and Specification
7.1.2.1 Ambient
7.1.2.2 Chilled
7.1.3 Coca-Cola Baby Fruit Juice Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Fresh Del Monte Produce
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Baby Fruit Juice Product Type, Application and Specification
7.2.2.1 Ambient
7.2.2.2 Chilled
7.2.3 Fresh Del Monte Produce Baby Fruit Juice Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 Dr Pepper Snapple
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Baby Fruit Juice Product Type, Application and Specification
7.3.2.1 Ambient
7.3.2.2 Chilled
7.3.3 Dr Pepper Snapple Baby Fruit Juice Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Nestlé

Continued…..

For Detailed Reading Please visit WiseGuy Reports @ https://www.wiseguyreports.com/reports/898950-global-baby-fruit-juice-market-research-report-2017

About Us
Wise Guy Reports is part of the Wise Guy Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Wise Guy Reports understand how essential statistical surveying information is for your organization or association. Therefore, we have associated with the top publishers and research firms all specialized in specific domains, ensuring you will receive the most reliable and up to date research data available.

Contact Us:
Norah Trent
+1 646 845 9349 / +44 208 133 9349
Follow on LinkedIn: https://www.linkedin.com/company/wise-guy-research-consultants-pvt-ltd-?trk=biz-companies-cym

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire

Frozen Potatoes Market 2017- Global Industry Analysis, Size, Share, Growth, Trends and Forecast by 2022

Frozen Potatoes Industry

WiseGuyReports.com adds “Frozen Potatoes Market 2017 Global Analysis, Growth, Trends, Opportunities Research Report Forecasting to 2022”reports to its database.

PUNE, INDIA, September 19, 2017 /EINPresswire.com/ — Frozen Potatoes Market:

Executive Summary

Based on the Frozen Potatoes industrial chain, this report mainly elaborate the definition, types, applications and major players of Frozen Potatoes market in details. Deep analysis about market status (2012-2017), enterprise competition pattern, advantages and disadvantages of enterprise Products, industry development trends (2017-2022), regional industrial layout characteristics and macroeconomic policies, industrial policy has also be included. From raw materials to downstream buyers of this industry will be analyzed scientifically, the feature of product circulation and sales channel will be presented as well. In a word, this report will help you to establish a panorama of industrial development and characteristics of the Frozen Potatoes market.

The Frozen Potatoes market can be split based on product types, major applications, and important regions.

Major Players in Frozen Potatoes market are:

Seneca Foods
McCain Foods
Iceland Foods
Bonduelle
Landun
General Mills
Goya Foods
Ardo
Kraft Heinz
Conagra Foods
Farm Frites
Alyasra Foods
Nahrungsmittel
Nomad Foods
Pizzoli
Simplot Food
Aviko Group
Tyson Foods
Agristo

Request Sample Report @ https://www.wiseguyreports.com/sample-request/2311486-global-frozen-potatoes-industry-market-research-report

Major Regions play vital role in Frozen Potatoes market are:

North America
Europe
China
Japan
Middle East & Africa
India
South America
Others

Most important types of Frozen Potatoes products covered in this report are:

Non-chips
Chips

Most widely used downstream fields of Frozen Potatoes market covered in this report are:

Household
Restaurant (QSR)
Others

For further information on this report, visit – https://www.wiseguyreports.com/enquiry/2311486-global-frozen-potatoes-industry-market-research-report

Table of Content:

Global Frozen Potatoes Industry Market Research Report 
1 Frozen Potatoes Introduction and Market Overview 
    1.1 Objectives of the Study 
    1.2 Definition of Frozen Potatoes 
    1.3 Frozen Potatoes Market Scope and Market Size Estimation 
      1.3.1 Market Concentration Ratio and Market Maturity Analysis 
      1.3.2 Global Frozen Potatoes Value ($) and Growth Rate from 2012-2022 
    1.4 Market Segmentation 
      1.4.1 Types of Frozen Potatoes 
      1.4.2 Applications of Frozen Potatoes 
      1.4.3 Research Regions 
          1.4.3.1 North America Frozen Potatoes Production Value ($) and Growth Rate (2012-2017) 
          1.4.3.2 Europe Frozen Potatoes Production Value ($) and Growth Rate (2012-2017) 
          1.4.3.3 China Frozen Potatoes Production Value ($) and Growth Rate (2012-2017) 
          1.4.3.4 Japan Frozen Potatoes Production Value ($) and Growth Rate (2012-2017) 
          1.4.3.5 Middle East & Africa Frozen Potatoes Production Value ($) and Growth Rate (2012-2017) 
          1.4.3.6 India Frozen Potatoes Production Value ($) and Growth Rate (2012-2017) 
          1.4.3.7 South America Frozen Potatoes Production Value ($) and Growth Rate (2012-2017) 
    1.5 Market Dynamics 
      1.5.1 Drivers 
          1.5.1.1 Emerging Countries of Frozen Potatoes 
          1.5.1.2 Growing Market of Frozen Potatoes 
      1.5.2 Limitations 
      1.5.3 Opportunities 
    1.6 Industry News and Policies by Regions 
      1.6.1 Industry News 
      1.6.2 Industry Policies

2 Industry Chain Analysis 
    2.1 Upstream Raw Material Suppliers of Frozen Potatoes Analysis 
    2.2 Major Players of Frozen Potatoes 
      2.2.1 Major Players Manufacturing Base and Market Share of Frozen Potatoes in 2016 
      2.2.2 Major Players Product Types in 2016 
    2.3 Frozen Potatoes Manufacturing Cost Structure Analysis 
      2.3.1 Production Process Analysis 
      2.3.2 Manufacturing Cost Structure of Frozen Potatoes 
      2.3.3 Raw Material Cost of Frozen Potatoes 
      2.3.4 Labor Cost of Frozen Potatoes 
    2.4 Market Channel Analysis of Frozen Potatoes 
    2.5 Major Downstream Buyers of Frozen Potatoes Analysis

3 Global Frozen Potatoes Market, by Type 
    3.1 Analysis of Market Status and Feature by Type 
    3.2 Global Frozen Potatoes Value ($) and Market Share by Type (2012-2017) 
    3.3 Global Frozen Potatoes Production and Market Share by Type (2012-2017) 
    3.4 Global Frozen Potatoes Value ($) and Growth Rate by Type (2012-2017) 
    3.5 Global Frozen Potatoes Price Analysis by Type (2012-2017)

4 Frozen Potatoes Market, by Application 
    4.1 Downstream Market Overview 
    4.2 Global Frozen Potatoes Consumption and Market Share by Application (2012-2017) 
    4.3 Downstream Buyers by Application 
    4.4 Global Frozen Potatoes Consumption and Growth Rate by Application (2012-2017)

5 Global Frozen Potatoes Production, Value ($) by Region (2012-2017) 
    5.1 Global Frozen Potatoes Value ($) and Market Share by Region (2012-2017) 
    5.2 Global Frozen Potatoes Production and Market Share by Region (2012-2017) 
    5.3 Global Frozen Potatoes Production, Value ($), Price and Gross Margin (2012-2017) 
    5.4 North America Frozen Potatoes Production, Value ($), Price and Gross Margin (2012-2017) 
    5.5 Europe Frozen Potatoes Production, Value ($), Price and Gross Margin (2012-2017) 
    5.6 China Frozen Potatoes Production, Value ($), Price and Gross Margin (2012-2017) 
    5.7 Japan Frozen Potatoes Production, Value ($), Price and Gross Margin (2012-2017) 
    5.8 Middle East & Africa Frozen Potatoes Production, Value ($), Price and Gross Margin (2012-2017) 
    5.9 India Frozen Potatoes Production, Value ($), Price and Gross Margin (2012-2017) 
    5.10 South America Frozen Potatoes Production, Value ($), Price and Gross Margin (2012-2017)

6 Global Frozen Potatoes Production, Consumption, Export, Import by Regions (2012-2017) 
    6.1 Global Frozen Potatoes Consumption by Regions (2012-2017) 
    6.2 North America Frozen Potatoes Production, Consumption, Export, Import (2012-2017) 
    6.3 Europe Frozen Potatoes Production, Consumption, Export, Import (2012-2017) 
    6.4 China Frozen Potatoes Production, Consumption, Export, Import (2012-2017) 
    6.5 Japan Frozen Potatoes Production, Consumption, Export, Import (2012-2017) 
    6.6 Middle East & Africa Frozen Potatoes Production, Consumption, Export, Import (2012-2017) 
    6.7 India Frozen Potatoes Production, Consumption, Export, Import (2012-2017) 
    6.8 South America Frozen Potatoes Production, Consumption, Export, Import (2012-2017)

7 Global Frozen Potatoes Market Status and SWOT Analysis by Regions 
    7.1 North America Frozen Potatoes Market Status and SWOT Analysis 
    7.2 Europe Frozen Potatoes Market Status and SWOT Analysis 
    7.3 China Frozen Potatoes Market Status and SWOT Analysis 
    7.4 Japan Frozen Potatoes Market Status and SWOT Analysis 
    7.5 Middle East & Africa Frozen Potatoes Market Status and SWOT Analysis 
    7.6 India Frozen Potatoes Market Status and SWOT Analysis 
    7.7 South America Frozen Potatoes Market Status and SWOT Analysis

8 Competitive Landscape 
    8.1 Competitive Profile 
Agristo8.20 Agristo 

Continued…

Buy this Report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=2311486

Norah Trent
WiseGuy Research Consultants Pvt. Ltd.
+1 646 845 9349 / +44 208 133 9349
email us here


Source: EIN Presswire